102 related articles for article (PubMed ID: 6189331)
1. The effect of UVB light on serum concentrations of 5-S-cysteinyldopa.
Tegner E; Agrup G; Rosengren E
Acta Derm Venereol; 1983; 63(2):149-52. PubMed ID: 6189331
[No Abstract] [Full Text] [Related]
2. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
3. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
Hansson C; Rorsman H; Rosengren E; Tegner E
Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
[TBL] [Abstract][Full Text] [Related]
4. 5-S-cysteinyldopa and pigment response to UVA light.
Tegner E; Rorsman H; Rosengren E
Acta Derm Venereol; 1983; 63(1):21-5. PubMed ID: 6191484
[TBL] [Abstract][Full Text] [Related]
5. Increased cysteinyldopa plasma levels hint to melanocyte as stress sensor in psoriasis.
Panzella L; Wakamatsu K; Monfrecola G; Ito S; Ayala F; Napolitano A
Exp Dermatol; 2011 Mar; 20(3):288-90. PubMed ID: 21323749
[TBL] [Abstract][Full Text] [Related]
6. 5-S-cysteinyldopa excretion after treatment with 8-methoxypsoralen and UVA light.
Agrup G; Hansson C; Rorsman H; Rosengren A-M ; Rosengren E; Tegner E
J Invest Dermatol; 1978 Jan; 70(1):25-6. PubMed ID: 618976
[TBL] [Abstract][Full Text] [Related]
7. UVB-induced melanocyte proliferation and 5-S-cysteinyldopa excretion in dysplastic nevus syndrome.
Stierner U; Augustsson A; Rosdahl I; Kågedal B; Suurküla M
Photodermatol; 1988 Oct; 5(5):218-23. PubMed ID: 3146749
[TBL] [Abstract][Full Text] [Related]
8. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
Nimmo JE; Hunter JA; Percy-Robb IW; Jay B; Phillips CI; Taylor WO
Acta Derm Venereol; 1985; 65(2):169-71. PubMed ID: 2408424
[TBL] [Abstract][Full Text] [Related]
9. Observations on PUVA treatment of psoriasis and on 5-S-cysteinyldopa after exposure to UV light.
Tegner E
Acta Derm Venereol Suppl (Stockh); 1983; 107():1-68. PubMed ID: 6410637
[No Abstract] [Full Text] [Related]
10. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
Hansson C; Wirestrand LE; Aronsson A; Rorsman H; Rosengren E
Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
[TBL] [Abstract][Full Text] [Related]
11. Plasma 5-S-cysteinyldopa as an index of melanogenesis.
Nimmo JE; Gawkrodger DJ; O'Docherty CS; Going SM; Percy-Robb IW; Hunter JA
Br J Dermatol; 1988 Apr; 118(4):487-95. PubMed ID: 3132198
[TBL] [Abstract][Full Text] [Related]
12. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
Agrup G; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
[TBL] [Abstract][Full Text] [Related]
13. Soluble tumor necrosis factor alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
Serwin AB; Sokolowska M; Chodynicka B
Photodermatol Photoimmunol Photomed; 2005 Aug; 21(4):210-1. PubMed ID: 15998370
[TBL] [Abstract][Full Text] [Related]
14. Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
Marnot D; Decaux F; Berthelot P; Kalis B; Jardillier JC; Warren L
Cancer Detect Prev; 1983; 6(1-2):303-10. PubMed ID: 6411338
[TBL] [Abstract][Full Text] [Related]
15. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
Hansson C; Edholm LE; Agrup G; Rorsman H; Rosengren AM; Rosengren E
Clin Chim Acta; 1978 Sep; 88(3):419-27. PubMed ID: 699334
[TBL] [Abstract][Full Text] [Related]
16. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
Hansson C; Agrup G; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(2):155-56. PubMed ID: 6155023
[TBL] [Abstract][Full Text] [Related]
17. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
Bourke JF; Iqbal SJ; Hutchinson PE
Clin Exp Dermatol; 1997 Nov; 22(6):259-61. PubMed ID: 9604449
[TBL] [Abstract][Full Text] [Related]
18. [Urinary 5-S-cysteinyldopa in malignant melanoma subjects-with special reference to melanoma stages and dopa loading test (author's transl)].
Ichihasi M; Mojamdar M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1045-9. PubMed ID: 6798247
[No Abstract] [Full Text] [Related]
19. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
20. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.
Bagel J
J Drugs Dermatol; 2009 Apr; 8(4):351-7. PubMed ID: 19363853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
